Literature DB >> 10375366

Safety and effectiveness of BCG vaccination in preterm babies.

S Thayyil-Sudhan1, A Kumar, M Singh, V K Paul, A K Deorari.   

Abstract

AIM: To assess the cell mediated immune response to BCG vaccine in preterm babies.
METHODS: Sixty two consecutive preterm babies born at < 35 weeks of gestation were randomly allocated into two groups. Babies in group A were vaccinated early at 34-35 weeks and group B were vaccinated late at 38-40 weeks of postconceptional age. The two groups were similar in terms of: gestational age (mean (SD) 33.1 (1. 1) and 33 (1.2) weeks, respectively); birthweight 1583 (204) and 1546 (218) g; neonatal problems; socioeconomic status; and postnatal weight gain. The cell mediated immune response to BCG was assessed using the Mantoux test and the lymphocyte migration inhibition test (LMIT) 6-8 weeks after BCG vaccination. Induration of >5 mm after the Mantoux test was taken as a positive response.
RESULTS: There was no significant difference in the tuberculin conversion rates (80% and 80.7%, respectively), positive LMIT (86.6% and 90.3%, respectively), or BCG scar (90.0% and 87.1%, respectively) among the two groups.
CONCLUSIONS: Prematurity seems to be an unlikely cause for poor vaccine uptake. Preterm babies can be effectively vaccinated with BCG at 34-35 weeks of postconceptional age, the normal time of discharge in a developing country.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375366      PMCID: PMC1720954          DOI: 10.1136/fn.81.1.f64

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  14 in total

Review 1.  Neonatal BCG immunisation.

Authors:  A Clarke; P Rudd
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

2.  Is zero dose oral polio vaccine effective in preterm babies?

Authors:  S Thayyil-Sudhan; M Singh; S Broor; I Xess; V K Paul; A K Deorari
Journal:  Ann Trop Paediatr       Date:  1998-12

3.  Does BCG vaccine prevent tuberculous meningitis?

Authors:  N Thilothammal; P V Krishnamurthy; D K Runyan; K Banu
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

4.  BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD.

Authors:  A A Ferreira; M M Bunn-Moreno; C C Sant'Anna; M F Ferreira
Journal:  Tuber Lung Dis       Date:  1996-10

5.  Tuberculin response in preterm infants after BCG vaccination at birth.

Authors:  M R Sedaghatian; K Kardouni
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

6.  Cell mediated immune responses in BCG vaccinated children.

Authors:  V Vijayalakshmi; P S Devi; K J Murthy; D V Rao; S N Jain
Journal:  Indian Pediatr       Date:  1993-07       Impact factor: 1.411

7.  Bacille Calmette Guérin vaccination in pre-term infants.

Authors:  M R Sedaghatian; F Hashem; M Moshaddeque Hossain
Journal:  Int J Tuberc Lung Dis       Date:  1998-08       Impact factor: 2.373

8.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Authors:  G A Colditz; T F Brewer; C S Berkey; M E Wilson; E Burdick; H V Fineberg; F Mosteller
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

9.  Effectiveness of BCG vaccination against tuberculous meningitis: a case-control study in São Paulo, Brazil.

Authors:  V Wünsch Filho; E A de Castilho; L C Rodrigues; S R Huttly
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

10.  BCG vaccination of full-term infants with chronic intrauterine malnutrition: influence of immunization age on development of post-vaccination, delayed tuberculin hypersensitivity.

Authors:  M M Mussi-Pinhata; A L Goncalves; N T Foss
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

View more
  7 in total

1.  Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.

Authors:  Megha Saroha; M M A Faridi; Prerna Batra; Iqbal Kaur; D K Dewan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring.

Authors:  Janine Jason; Lennox K Archibald; Okey C Nwanyanwu; Peter N Kazembe; Julie A Chatt; Elizabeth Norton; Hamish Dobbie; William R Jarvis
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 3.  Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.

Authors:  Carl T D'Angio
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

4.  Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age.

Authors:  Archana Kulkarni-Munje; Nandini Malshe; Sonali Palkar; Aniket Amlekar; Sanjay Lalwani; Akhilesh Chandra Mishra; Vidya Arankalle
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

5.  Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.

Authors:  Shiraz Badurdeen; Andrew Marshall; Hazel Daish; Mark Hatherill; James A Berkley
Journal:  JAMA Pediatr       Date:  2019-01-01       Impact factor: 16.193

6.  Determinants of Bacille Calmette-Guérin scarification in Danish children.

Authors:  Trine Mølbæk Jensen; Signe Kjeldgaard Jensen; Nina Marie Birk; Andreas Rieckmann; Thomas Hoffmann; Christine Stabell Benn; Dorthe Lisbeth Jeppesen; Ole Pryds; Thomas Nørrelykke Nissen
Journal:  Heliyon       Date:  2021-01-04

7.  Scar formation and tuberculin conversion following BCG vaccination in infants: A prospective cohort study.

Authors:  Sara S Dhanawade; Suhas G Kumbhar; Alka D Gore; Vijay N Patil
Journal:  J Family Med Prim Care       Date:  2015 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.